Metabolism and pharmacokinetics of the cardiotonic agent piroximone and of its major metabolite in dog

References

• Bannenberg G., Netter K. J., Maser E. 11 Beta-hydroxysteroid dehydrogenase involved in reductive metabolism of xenobiotic carbonyl compounds. Presented at the thirteenth European Workshop on Drug Metabolism, BergamoItaly, September, 21–251992
   Google Scholar
• Berg-Candolfi M., Borlakoglu J. T., Dulery B., Jehl F., Haegele K. D. Assessment of the biotransformation of the cardiotonic agent piroximone by high-performance liquid chromatography and gas chromatography-mass spectrometry. Journal of Chromatography 1992; 593: 1–7
   PubMedGoogle Scholar
• Boxenbaum H. G., Jodhka G. S., Ferguson A. C., Riegelman S., Mac Gregor T. R. The influence of bacterial gut hydrolysis on the fate of orally administered isonicotinuric acid in man. Journal of Pharmacokinetics and Biopharmaceutics 1974; 2: 211–237
   PubMedGoogle Scholar
• Chen T. M., Coutant J. E., Sill A. R., Fike R. R. Thermospray high-performance liquid chromatographic-mass spectrometric analysis of the degradation products of piroximone. Journal of Chromatography 1987; 396: 382–388
   Google Scholar
• Cheng H. C., Kariya T., Gleason E. M., Dage R. C. Studies on the mechanism of the positive inotropic effect of piroximone in cat papillary muscle. Journal of Cardiovascular Pharmacology 1985; 7: 747–752
   Google Scholar
• Dage R. C., Okerholm R. A. Pharmacology and pharmacokinetics of enoximone. Cardiology 1990; 77: 2–13
   Google Scholar
• Dage R. C., Roebel L. E., Hsieh C. P., Woodward J. K. Cardiovascular properties of a new cardiotonic agent, MDL 19205. Journal of Cardiovascular Pharmacology 1984; 6: 35–42
   PubMed Web of Science ®Google Scholar
• Dale J. A., Dull D. L., Mosher H. S. Alpha-methoxy-alpha-trifluoromethylphenylacetic acid, a versatile reagent for the determination of enantiomeric composition of alcohols and amines. Journal of Organic Chemistry 1969; 34: 2543–2549
   Web of Science ®Google Scholar
• Dale J. A., Mosher H. S. Nuclear magnetic resonance enantiomer reagents. Configurational correlations via nuclear magnetic resonance chemical shifts of diastereoisomeric mandelate, O-methylmandelate and alpha-methoxy-alpha-trifluoromethylphenylacetate (MTPA) esters. Journal of the American Chemical Society 1973; 95: 512–519
   Web of Science ®Google Scholar
• Evans A. M., Nation R. L., Sansom L. N., Bochner F., Somogyi A. A. Stereoselective drug disposition: potential for misinterpretation of drug disposition data. British Journal of Clinical Pharmacology 1988; 26: 771–780
   PubMedGoogle Scholar
• Gibaldi M., Perrier D. Pharmacokinetics. Marcel Dekker, New York 1982
   Google Scholar
• Guzman M., Troncoso A. M., Guillen R., Benitez M. Isonicotinic acid: properties and analytical methods. A review. Bollettino Chimico Farmaceutico 1984; 123: 200–209
   Google Scholar
• Haegele K. D., Hinze C., Joder-Ohlenbusch A. M., Cremer G., Borlak J. Effects of a standardized meal on the pharmacokinetics of the new carditonic agent piroximone. Arzneimittel Forschung 1991; 41: 1225–1229
   PubMedGoogle Scholar
• Hutt A. J. Enantiospecific analytical methodology: applications in drug metabolism and pharmacokinetics. Progress in Drug Metabolism 1990; 12: 257–361
   Google Scholar
• Jamali F., Mehvar R., Pasutto F. M. Enantioselective aspects of drug action and disposition: therapeutic pitfalls. Journal of Pharmaceutical Sciences 1989; 78: 695–715
   PubMed Web of Science ®Google Scholar
• Kariya T., Wille L. J., Dage R. C. Studies on the mechanism of the cardiotonic activity of MDL 19205: effects on several biochemical systems. Journal of Cardiovascular Pharmacology 1984; 6: 50–55
   PubMed Web of Science ®Google Scholar
• Karoum F., Gillin J. C., Wyatt R. J., Costa E. Mass-fragmentography of nanogram quantities of biogenic amine metabolites in human cerebrospinal fluid and whole rat brain. Biomedical Mass Spectrometry 1975; 2: 183–189
   Google Scholar
• Keeley F. J., Theile J. D., Garteiz D. A., Weiner D. L., Okerholm R. A. Method of analysis of the new cardiotonic agent. MDL 19205, in plasma and urine and its application in dog pharmacokinetic study. Journal of Chromatography 1983; 278: 379–385
   Google Scholar
• Krstulovic A. M. Racemates versus enantiomerically pure drugs: putting high-performance liquid chromatography to work in the selection process. Journal of Chromatography. Biomedical Applications 1989; 488: 53–72
   PubMedGoogle Scholar
• Le Corre P., Sado P., Le Verge R. Influence de la chiralité en pharmacologie clinique. Journal de Pharmacie de Belgique 1991; 46: 331–347
   Google Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Martin B. K. Drug urinary excretion data: some aspects concerning the interpretation. British Journal of Pharmacology and Chemotherapy 1967; 29: 181–193
   PubMed Web of Science ®Google Scholar
• Metha A. C. Chiral high performance liquid chromatography of drug molecules. Journal of Clinical Pharmacy and Therapeutics 1990; 15: 313–323
   Google Scholar
• Reed G. A. Co-oxidation of xenobiotics: lipid peroxyl derivatives as mediators of metabolism. Chemistry and Physics of Lipids 1987; 44: 127–148
   PubMedGoogle Scholar
• Roebel L. E., Dage R. C., Cheng H. C., Woodward J. K. In vitro and in vivo assessment of the cardiovascular effects of the cardiotonic drug MDL 19205. Journal of Cardiovascular Pharmacology 1984; 6: 43–49
   PubMed Web of Science ®Google Scholar
• Rowland M., Tozer T. N. Clinical Pharmacokinetics; Concepts and Applications. Henry Kimpton, London 1980
   Google Scholar
• Schnettler R. A., Dage R. C., Grisar J. M. 4-aroyl-1,3,-dihydro-2H-imidazol-2-ones, a new class of cardiotonic agents. Journal of Medicinal Chemistry 1982; 25: 1477–1481
   Google Scholar
• Schnettler R. A., Dage R. C., Palopoli F. P. 4-aroyl-1,3-dihydro-2H-imidazol-2-ones; a new class of cardiotonic agents. 2. Effects of 4-pyridoyl substituents and related compounds. Journal of Medicinal Chemistry 1986; 29: 860–862
   Google Scholar
• Smith D. A. Species differences in metabolism and pharmacokinetics: are we close to an understanding. Drug Metabolism Review 1991; 23: 355–373
   PubMed Web of Science ®Google Scholar
• Spector W. S. Handbook of Biological Data. W. B. Sauders, London 1956
   Google Scholar
• Testa B., Jenner P. Drug Metabolism: Chemical and Biochemical Aspects. Marcel Dekker, New York 1982
   Google Scholar
• Trevor A., Rowland M., Way E. L. Techniques for studying drug disposition in vivo. Fundamentals of Drug Metabolism and Disposition, B. N. La Du, H. G. Mandel, E. L. Way. Williams & Wilkins, Baltimore 1971; 369–399
   Google Scholar
• Tsuge O., Oe K., Inoue H. Photocyclization and Photooxygenation of 1,3,4,5-tetraarylimidazolin-2-ones. Heterocycles 1979; 12: 217–225
   Google Scholar